Diffuse intrinsic pontine glioma (DIPG) is a fatal brain tumor. Herein, we report on novel prognostic and predictive genomic biomarkers identified in PNOC003, a multi-center precision medicine trial for children and young adults diagnosed with DIPG.
Neuro-Oncology DIPG-31 Prognostic and predictive biomarkers for H3K27M-altered diffuse intrinsic pontine glioma from PNOC003
Previous
Previous
Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer
Next
Next